Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-26-012063

Director sold 70,000 shares at $27.45 ($1,921,500)

  • Director acquired 70,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Fitzgerald Meghan · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-26 Exercise or conversion : show line 1 in the form +70,000 $8.80 $616,000 112,963 D
2026-03-26 Sale : show line 2 in the form −70,000 $27.45 $1,921,500 42,963 D
Open-market sales · 70,000 sh · avg $27.45 · $1,921,500

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-26 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −70,000 48,578 D
Loading xslF345X06/form4.xml…